Jupiter Research Capital (Asia) Ltd’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
Other funds holding MLTX
Jupiter Research Capital (Asia) Ltd's MLTX Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd sold out of MoonLake Immunotherapeutics (MLTX) in Q3 2026, closing a stake of 13,075 shares — an estimated $255K sold.
Jupiter Research Capital (Asia) Ltd first reported a position in MLTX in Q4 2025 and held it in 3 quarters. The position peaked at $460K in Q1 2026. 149 funds tracked by Wall St. Rank hold MLTX as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd reported no remaining MoonLake Immunotherapeutics position as of Q3 2026 after selling out during the quarter.
- Jupiter Research Capital (Asia) Ltd sold 13,075 MoonLake Immunotherapeutics shares in Q3 2026, an estimated $255K.
- Jupiter Research Capital (Asia) Ltd first reported a position in MoonLake Immunotherapeutics in Q4 2025 and held it in 3 quarters.
- Jupiter Research Capital (Asia) Ltd's MoonLake Immunotherapeutics position peaked at $460K in Q1 2026.
- 149 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.